PMID: 9541097Apr 16, 1998Paper

Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies

Lupus
E HachullaB Devulder

Abstract

To determine in patients with systemic lupus erythematosus (SLE) or with primary antiphospholipid syndrome (PAPS) the prevalence of cerebral magnetic resonance imaging changes (MRI) and the relationship with antiphospholipid antibodies. Twenty-nine consecutive SLE patients, 24 PAPS patients and 31 healthy controls were prospectively included in the study and underwent MRI Scan over a 1-year period. MRI scans were analyzed separately by a neuroradiologist for white matter changes [periventricular hyperintensity (PVH) (0-6 scale), deep white matter hyperintensity (WMH) (0-24 scale)], and one neurologist for cerebral atrophy (0-39 scale) and stroke subtypes. Statistical assessment consisted of a discriminant analysis performed with SAS-package with MRI data as dependent variables and, as independent variables, age, sex, arterial hypertension, diabetes mellitus, cardiopathy, migraine, neurological symptoms, antiphospholipid antibodies, SLE, steroid treatment. The prevalence of cerebral atrophy was increased in both SLE and PAPS groups relative to controls. PVH and WMH scores were significantly higher in SLE and PAPS than in controls. Focal infarct did not differ in the SLE group when compared with PAPS. PVH and WMH scores were sign...Continue Reading

References

Jan 1, 1978·Journal of Computer Assisted Tomography·J BentsonG Wilson
Dec 15, 1992·Annals of Internal Medicine·K S GinsburgM J Stampfer
Oct 1, 1990·Seminars in Arthritis and Rheumatism·L R SammaritanoM D Lockshin
Mar 1, 1990·Acta Neurologica Scandinavica·E KinnunenM Koskenvuo
Mar 1, 1989·Annals of Neurology·D P BrileyS H Goodnight
Mar 1, 1986·AJR. American Journal of Roentgenology·R D ZimmermanM D Deck
Jul 1, 1986·Neurology·G Gerard, L A Weisberg
Apr 1, 1985·Annals of the Rheumatic Diseases·E N HarrisG R Hughes
Nov 1, 1982·Arthritis and Rheumatism·E M TanR J Winchester
May 1, 1995·Stroke; a Journal of Cerebral Circulation·R SchmidtP Kapeller
Dec 1, 1993·Acta Neurologica Scandinavica·E KinnunenR Sepponen
Sep 1, 1993·Headache·M SilvestriniG Bernardi
Apr 1, 1993·Seminars in Arthritis and Rheumatism·M M StimmlerF P Quismorio

❮ Previous
Next ❯

Citations

Oct 19, 1999·Arthritis and Rheumatism·W L SibbittW M Brooks
Jul 28, 2009·Journal of Neurology·Milena StosicRobert Zivadinov
Oct 6, 2005·Journal of Thrombosis and Thrombolysis·Robin L Brey
Jul 20, 2002·Clinical Neurology and Neurosurgery·Vesna V Brinar
Mar 14, 2012·Journal of the International Neuropsychological Society : JINS·Thomas J CoveyRalph H B Benedict
Jan 25, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·M RovarisM Filippi
Jul 27, 2007·Vestnik oftalmologii·T V Smirnova
Feb 18, 2006·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Carlos A RoldanWilmer L Sibbitt
Jun 18, 1999·The American Journal of the Medical Sciences·A AmorosoA Afeltra
Oct 16, 2010·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Akio KimuraTakashi Inuzuka
May 22, 2007·Journal of Neuroimmunology·Neeta GargBianca Weinstock-Guttman
Jan 15, 2008·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Sergio I Valdés-FerrerAntonio R Cabral
Apr 20, 2010·Annals of the New York Academy of Sciences·Joerg SchedelUlf Mueller-Ladner
Apr 28, 2005·Clinical Imaging·Marcelo R AbreuFlávio Kapczinsky
Apr 18, 2003·Seminars in Arthritis and Rheumatism·Armin SchnabelWolfgang L Gross
May 18, 2018·Lupus·I F RicarteD Andrade
Apr 30, 2020·Current Opinion in Neurology·Meggan MackayAn Vo
May 16, 2007·Current Rheumatology Reports·Jose F Roldan, Robin L Brey
Mar 31, 2021·Current Rheumatology Reports·Aida ZarfeshaniBetty Diamond
May 27, 2021·Scientific Reports·L A DobryninaM V Krotenkova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.